Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 


Jnk inhibitor
ALX-270-443-M001 1 mg 70.00 USD
ALX-270-443-M005 5 mg 212.00 USD
ALX-270-443-M025 25 mg 805.00 USD
Do you need bulk/larger quantities?
Potent and cell permeable ATP competitive JNK inhibitor (hJNK1: IC50=150nM, hJNK2: IC50=220nM and hJNK3: IC50=70 nM). Displays anti-inflammatory properties and has been shown to reduce TNF-α plasma levels induced by LPS in mice.

Product Details

Alternative Name:1,3-Benzothiazol-2-yl-(2-{[2-(3-pyridinyl)ethyl]amino}-4-pyrimidinyl) acetonitrile, JNK Inhibitor V
Purity:≥95% (HPLC)
Purity Detail:Sum of two isomers.
Identity:Determined by 1H-NMR.
Appearance:White to yellow solid.
Solubility:Soluble in DMSO (10mg/ml).
Shipping:Ambient Temperature
Long Term Storage:-20°C
Use/Stability:Stock solutions are stable for up to 3 months when stored at -20°C.
Handling:Hygroscopic. Packaged under inert gas. Protect from light.
Regulatory Status:RUO - Research Use Only
Please mouse over

Product Literature References

EPA Prevents the Development of Abdominal Aortic Aneurysms through Gpr-120/Ffar-4: R. Kamata, et al.; PLoS One 11, e0165132 (2016), Application(s): Cell culture, Mouse aortic SMCs , Abstract; Full Text
Design and synthesis of the first generation of novel potent, selective, and in vivo active (benzothiazol-2-yl)acetonitrile inhibitors of the c-Jun N-terminal kinase: P. Gaillard, et al.; J. Med. Chem. 48, 4596 (2005), Abstract;
AS601245 (1,3-benzothiazol-2-yl (2-[[2-(3-pyridinyl) ethyl] amino]-4 pyrimidinyl) acetonitrile): a c-Jun NH2-terminal protein kinase inhibitor with neuroprotective properties: S. Carboni, et al.; J. Pharmacol. Exp. Ther. 310, 25 (2004), Abstract; Full Text

Related Literature

Integrated solutions for screening Wnt regulators
Integrated solutions for screening Wnt regulators
Download as PDF

Essential Research Tools for Neurodegeneration & Neural Signaling
Essential Research Tools for Neurodegeneration & Neural Signaling
Download as PDF

All new literature pieces